Product

SKL27969

1 clinical trial

1 indication

Indication

Advanced Solid Tumor

Clinical trial

A Phase 1/2, Open-Label, Multicenter, Dose-Finding Study of SKL27969 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy in Patients With Advanced Solid Tumors

Status: Terminated, Estimated PCD: 2024-03-01